Skip to main content

ADVERTISEMENT

Jessica Garlewicz, Associate Digital Editor

Mark Lebwohl, MD,
Conference Coverage
10/23/2022
Jessica Garlewicz, Associate Digital Editor
During his session presented at the 2022 Fall Clinical Dermatology Conference, Mark Lebwohl, MD, went over the many treatment options for patients with psoriasis.
During his session presented at the 2022 Fall Clinical Dermatology Conference, Mark Lebwohl, MD, went over the many treatment options for patients with psoriasis.
During his session presented at...
10/23/2022
The Dermatologist
psoriasis severe
Conference Coverage
10/22/2022
Jessica Garlewicz, Associate Digital Editor
During her session, “IL-17 Blockers: Safety and Efficacy,” Boni E. Elewski, MD, went over the efficacy and safety of some of the IL-17 blockers used to treat psoriasis, and more.
During her session, “IL-17 Blockers: Safety and Efficacy,” Boni E. Elewski, MD, went over the efficacy and safety of some of the IL-17 blockers used to treat psoriasis, and more.
During her session, “IL-17...
10/22/2022
The Dermatologist
melanoma
Conference Coverage
10/21/2022
Jessica Garlewicz, Associate Digital Editor
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022...
10/21/2022
The Dermatologist
Elizabeth Swanson, MD
Conference Coverage
10/21/2022
Jessica Garlewicz, Associate Digital Editor
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and...
10/21/2022
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
10/21/2022
Jessica Garlewicz, Associate Digital Editor
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New...
10/21/2022
The Dermatologist
April W. Armstrong, MD, MPH
Conference Coverage
10/21/2022
Jessica Garlewicz, Associate Digital Editor
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at...
10/21/2022
The Dermatologist
swanson
Conference Coverage
10/20/2022
Jessica Garlewicz, Associate Digital Editor
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022...
10/20/2022
The Dermatologist
Conference Highlights
10/18/2022
Jessica Garlewicz, Associate Digital Editor
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology...
10/18/2022
The Dermatologist
Clinical Insights
10/18/2022
Jessica Garlewicz, Associate Digital Editor
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved...
10/18/2022
The Dermatologist
Jashin Wu, MD, FAAD
Q&As
10/14/2022
Jessica Garlewicz, Associate Digital Editor
A recent abstract summarized the current knowledge surrounding inflammatory mechanisms shared between psoriasis and metabolic syndrome.
A recent abstract summarized the current knowledge surrounding inflammatory mechanisms shared between psoriasis and metabolic syndrome.
A recent abstract summarized the...
10/14/2022
The Dermatologist